These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36624067)

  • 1. MRS in neurodegenerative dementias, prodromal syndromes and at-risk states: A systematic review of the literature.
    McKiernan E; Su L; O'Brien J
    NMR Biomed; 2023 Jul; 36(7):e4896. PubMed ID: 36624067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.
    Zhang B; Ferman TJ; Boeve BF; Smith GE; Maroney-Smith M; Spychalla AJ; Knopman DS; Jack CR; Petersen RC; Kantarci K
    J Neuroimaging; 2015; 25(2):269-274. PubMed ID: 25039916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies.
    Graff-Radford J; Boeve BF; Murray ME; Ferman TJ; Tosakulwong N; Lesnick TG; Maroney-Smith M; Senjem ML; Gunter J; Smith GE; Knopman DS; Jack CR; Dickson DW; Petersen RC; Kantarci K
    Neurobiol Aging; 2014 Jun; 35(6):1483-90. PubMed ID: 24468473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
    Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
    Mao C; You H; Hou B; Chu S; Jin W; Huang X; Shang L; Feng F; Peng B; Gao J
    J Alzheimers Dis; 2023; 93(2):509-519. PubMed ID: 37038812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Cerebral Network Differences in Prodromal Alzheimer's Disease and Prodromal Dementia with Lewy Bodies.
    Ota M; Nemoto K; Nemoto M; Numata Y; Kitabatake A; Yamada Y; Shinkawa K; Kobayashi M; Arai T
    Dement Geriatr Cogn Disord; 2022; 51(5):421-427. PubMed ID: 36574761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M; Moriya M; Nojo T
    J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H MR spectroscopy in common dementias.
    Kantarci K; Petersen RC; Boeve BF; Knopman DS; Tang-Wai DF; O'Brien PC; Weigand SD; Edland SD; Smith GE; Ivnik RJ; Ferman TJ; Tangalos EG; Jack CR
    Neurology; 2004 Oct; 63(8):1393-8. PubMed ID: 15505154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.
    Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V
    Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.
    Firbank MJ; Harrison RM; O'Brien JT
    Dement Geriatr Cogn Disord; 2002; 14(2):64-76. PubMed ID: 12145453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases.
    Seifan A; Ganzer CA; Ryon K; Lin M; Mahmudur R; Adolfo H; Shih C; Jacobs AR; Greenwald M; Isaacson RS
    Curr Aging Sci; 2019; 11(4):242-249. PubMed ID: 30845903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer's Disease and Frontotemporal Dementia.
    Nicastro N; Malpetti M; Cope TE; Bevan-Jones WR; Mak E; Passamonti L; Rowe JB; O'Brien JT
    J Alzheimers Dis; 2020; 76(1):331-340. PubMed ID: 32444550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer's disease.
    Zhong X; Shi H; Shen Z; Hou L; Luo X; Chen X; Liu S; Zhang Y; Zheng D; Tan Y; Huang G; Fang Y; Zhang H; Mu N; Chen J; Wu R; Ning Y
    J Alzheimers Dis; 2014; 40(4):953-66. PubMed ID: 24531156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias.
    Chai YL; Lee JH; Chong JR; Ballard C; Francis PT; Kennedy BK; Arumugam TV; Chen CP; Aarsland D; Lai MKP
    J Neuroinflammation; 2023 May; 20(1):111. PubMed ID: 37158957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
    Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
    Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI.
    Steketee RM; Bron EE; Meijboom R; Houston GC; Klein S; Mutsaerts HJ; Mendez Orellana CP; de Jong FJ; van Swieten JC; van der Lugt A; Smits M
    Eur Radiol; 2016 Jan; 26(1):244-53. PubMed ID: 26024845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
    Modrego PJ; Pina MA; Fayed N; Díaz M
    CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.